CYCLOSPORIN
CYCLOSPORIN
- Type of immunosuppressant drug.
- Specific T-cell Inhibitor/ calcineurin Inhibitor.
- Acts on CD4 cells & lymphocytes.
Major pharmacological effects:
Selective inhibition:
- Antigen-stimulated activation & proliferation of T-cells (CD4 helper cells).
- Expression IL-2 & other cytokines by T cells.
- Affects inducer T-cells response to IL-1, without affecting suppressor T-cells.
Mechanism of action:
- Binding protein – Cyclophilin.
- Inactivates calcineurin.
- Failure of antigenic stimulation by helper T-cell.
- Activates IL-2 inhibitor.
- Attenuating IL-2 stimulated T-cell proliferation.
- Block transcription of IL-2.
- Production of killer lymphocytes.
- Most active before antigen exposure.
- Suppress responses of primed helper T-cells.
- Hence, useful in auto-immune diseases.
Pharmacokinetics:
- Low oral bioavailability
- Bile-dependent
- Concentrated in WBC’s and RBC’s
- Metabolised in liver; Excreted in bile
- Biphasic plasma t1/2 – 4-6 hrs & 12-18 hrs
Advantages:
- Selectively suppresses cell-mediated immunity.
- Prevents graft rejection, unaffecting host’s immune system.
- No toxic effects on bone marrow & RE system (unlike cytotoxic immunosuppressants).
- Intact humoral immunity.
Adverse effects:
- Nephrotoxicity.
- Rise in serum creatinine levels.
- Reduced GFR.
- Impaired liver function.
- Post-transplant hypertension.
- Sustained rise in BP.
- Vasoconstriction & activation of RA system.
Other effects:
- Hyperuricemia.
- Hyperkalemia.
- Hypomagnesemia.
- Hirsutism.
- Gum hyperplasia.
- Tremor.
- Seizures.
- Precipitation of diabetes.
- Anorexia.
- Lethargy.
- Hyperkalemia.
- Viral infection.
Indications:
1. Prevention and treatment of graft rejection reaction
- Routinely used in renal, hepatic, cardiac, bone marrow and other transplants.
- Initial induction – Orally, 12 hrs prior transplant surgery.
- Maintenance dose – Until needed.
2. Autoimmune diseases – Second line drug.
- Severe rheumatoid arthritis, uveitis, IBD, psoriasis, & suppress acute exacerbations.
- Combined with glucocorticoid.
3. Aplastic anemia
- Low dose (2-5mg/kg/day).
- Not curative.
- Relapse on withdrawal.
Interactions:
1. Enhanced toxicity:
- Intake of nephrotoxic drugs.
- Vancomycin, Amphotericin B, & NSAIDS.
- Erythromycin & Ketoconazole (CYP3A4 inhibitors) inhibits its metabolism causing toxicity.
2. Excretory interference:
- Excretion of other drugs impaired by decreased renal function.
3. Drugs affecting cyclosporin:
- Phenytoin, Phenobarbitone & Rifampicin lower drug levels in blood.
- K+ supplements & K+ sparing diuretics produce marked hyperkalemia.
Exam Important
CYCLOSPORIN
- Specific T-cell Inhibitor/ Calcineurin Inhibitor
- Inactivates calcineurin.
- Acts by selective inhibition
- Suppress responses of primed helper T-cells
- Hence, useful in auto-immune diseases
- Bile-independent.
- Prevents graft rejection, unaffecting host’s immune system.
- No toxic effects on bone marrow & RE system.
Adverse effects:
- Nephrotoxicity
- Post-transplant hypertension
- Hyperuricemia, hyperkalemia & hypomagnesemia
- Hirsutism
- Gum hyperplasia
- Tremor
- Seizures
Indicated in:
- Prevention and treatment of graft rejection reaction.
- Routinely used in renal, hepatic, cardiac, bone marrow.
- Autoimmune diseases – Second line drug.
- Severe rheumatoid arthritis, uveitis, IBD, psoriasis.
- Aplastic anaemia.
Drug interactions:
- Enhanced toxicity when given along with Vancomycin, Amphotericin B, & NSAIDS.
Don’t Forget to Solve all the previous Year Question asked on CYCLOSPORIN
Click Here to Start Quiz
Click Here to Start Quiz


